September 25, 2026
Ohio State Wexner Medical Center named one of World’s Greenest Hospitals
The Ohio State University Wexner Medical Center has been named one of Newsweek's World’s Greenest Hospitals for 2026. Ohio State was one of two hospitals in Ohio included in the ranking, which recognizes institutions that are leading the way in sustainability by reducing emissions, conserving water and improving waste management. Some of Ohio State’s sustainability initiatives include diversion of medical and food waste through recycling and composting, incorporating telehealth visits to reduce gasoline and carbon dioxide emissions and expanding access to electric vehicle charging infrastructure.
Ohio State Wexner Medical Center joins Association of Membership Medicine Professionals
The Ohio State University Wexner Medical Center has joined the Association of Membership Medicine Professionals (AMMP) as a founding institutional partner. AMMP was established as a “big tent” professional home for stakeholders across the spectrum of membership medicine, including concierge medicine, direct primary care, system-based programs and emerging middle-ground membership models. AMMP was established as a “big tent” professional home for stakeholders across the spectrum of membership medicine, including concierge medicine, direct primary care, system-based programs, and emerging middle-ground membership models. Ohio State will help advance thoughtful innovation in primary care and the development of a stronger professional infrastructure for the growing membership medicine field.
Ohio State nurse-led glucose management model named Edge Runner
A nurse-led model developed by The Ohio State University College of Nursing faculty to improve glucose management for critically ill patients has been named an Edge Runner by the American Academy of Nursing. The program recognizes innovative, nurse-designed models that improve healthcare quality, reduce costs and enhance patient care. Eileen Faulds, PhD, APRN-CNP, assistant professor of nursing, developed the Hybrid CGM+POC Inpatient Glucose Management Model, which combines continuous glucose monitoring (CGM) with point-of-care testing and nursing protocols. Implementation of the model led The Ohio State University Wexner Medical Center to become the first U.S. health system to formally approve off-label CGM use as a standard of care across critical care environments. Faulds will be recognized at the organization’s Health Policy Conference in October.
3 Ohio State projects receive funding from Soter Women’s Health Research Program
Three teams of researchers at The Ohio State University College of Medicine have received funding from The Soter Women’s Health Research Program. The program established at Ohio State by Sarah “Sally” Ross Soter and the Soter Ziegler Foundation connects basic science with clinical and translational researchers to drive novel therapeutic approaches that address critical challenges in women’s health.
The programs funded:
- Priya Dedhia, MD, PhD, and Aleksander Skardal, PhD, for “Immune targeting of sexual dimorphism in adrenocortical carcinoma.” Women get adrenocortical carcinoma about 2.5 times more often than men, but researchers do not know why. The team will use lab-grown tumor models made from patient samples to study how the immune system may affect this cancer differently in women and men. They also will test possible treatment.
- Zeynep Saygin, PhD, and Maged Costantine, MD, for “Sex-specific neuroprotective factors in fetuses exposed to adverse intrauterine environments.” The project will look for factors that may protect a baby’s brain when the mother has high blood pressure during pregnancy. Researchers will use advanced MRI scans and wearable devices to study why female offspring may be less likely than males to develop brain and behavior problems after the same pregnancy complications.
- Aharon G. Freud, MD, PhD, Casey Cosgrove, MD, and Christopher C. Oakes, PhD, for “Clinical and Genetic Factors Molding NK cell Functions in Endometrial Cancer.” The study investigates how prior life events—specifically pregnancy and viral infections like cytomegalovirus —reprogram natural killer (NK) cells, which are part of the immune system. Researchers want to learn which patients are most likely to benefit from immune-based cancer treatments.
Ohio State’s Women and Infants team recognized for birth care
The Ohio State University Wexner Medical Center’s Women and Infants team earned TeamBirth Recognition from Unravel Healthcare. The designation is awarded to institutions that demonstrate a commitment to teamwork, clear communication and dignity throughout the birth experience.
CBD may help improve sleep, reduce seizures in Angelman syndrome study
Neuroscience researchers with The Ohio State University Wexner Medical Center found that cannabidiol, or CBD, may help improve sleep and reduce seizures tied to Angelman syndrome, a rare genetic disorder that affects the nervous system. In a mouse study, CBD helped restore disrupted REM sleep and daytime naps and reduced seizures compared with placebo. The findings suggest CBD could be a promising area for future research into treatments for sleep problems and seizures linked to Angelman syndrome. Bin Gu, PhD, an assistant professor of neuroscience at The Ohio State University College of Medicine, led the research that is published in Neuropsychopharmacology. “This preclinical investigation of CBD in mice will guide the rational development of CBD-based therapies for Angelman syndrome and ultimately improve the quality of life of affected individuals and their caregivers,” Gu said.
Media Contact
Amy Colgan, Ohio State Wexner Medical Center Media Relations, Amy.Colgan@osumc.edu